TrialCirculation2020

Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.

Francesco Cosentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.